B-cell chronic lymphocytic leukemia Part II: Diagnostic criteria and the importance of individual patient’s prognosis assessment


Authors: T. Papajík;  M. Jarošová;  Z. Pikalová;  K. Indrák
Authors‘ workplace: Hemato-onkologická klinika FN a LF UP v Olomouci
Published in: Transfuze Hematol. dnes,12, 2006, No. 3, p. 132-139.
Category: Comprehensive Reports, Original Papers, Case Reports

Overview

B-cell chronic lymphocytic leukemia (B-CLL) represents most common leukemia in Western Europe and North America adult population. Accurate diagnosis of the disease based on leukemic cell immunophenotype analysis has principal importance in differential diagnostic distinction of B-CLL from other leukemized B-cell malignancies. Determination of strong and independent prognostic parameters in early and intermediate disease stage patients could lead to consideration of appropriate therapeutic approach. Assessment of IgVH mutational status, ZAP70 and CD38 expression levels, genetic aberrations and p53 gene mutations constitute modern tools for understanding of biologic behavior and potential aggressiveness of leukemic clone.

Key words:
B-cell chronic lymphocytic leukemia, diagnosis, immunocytology, cytogenetic, IgVH mutations, prognosis


Labels
Haematology Internal medicine Clinical oncology

Article was published in

Transfusion and Haematology Today

Issue 3

2006 Issue 3

Most read in this issue

This topic is also in:


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account